Drug · DIN 02023830
SULFACETAMIDE
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since October 4, 2019; first marketed December 31, 1994.
- Drug Identification Number (DIN)
- 02023830
- Company (DIN owner)
- Pharma Stulln Inc.Pointe-Claire, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Sulfacetamide S01AB04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SULFACETAMIDE SODIUM | 10 % |